Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03418866

Ligand	Ligand name	Chain	PDB	Tanimoto
C41	ALISKIREN	C,O	2V0Z	0.7
4FE	(2E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid	A	3CBG	0.71
C61	(2R,4S,5S,7S)-5-AMINO-N-BUTYL-4-HYDROXY-7-[4-METHOXY-3-(3-METHOXYPROPOXY)BENZYL]-2,8-DIMETHYLNONANAMIDE	C,O	2V10	0.72
DRS	(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid	A,B	3BXS	0.73
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A,C,E	1KYZ	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A	1JT2	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A	6ATJ	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A,B	1GKL	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A	1GWT	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A,B,C	2BJH	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A	1GW2	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A	3CBG	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A	2BNJ	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A,B	1UWC	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A	7ATJ	0.71
ANM	ANISOMYCIN	1,2,4,A,B,C,D,E,J,K,L,M,N,O,P,R,S,T,U,V,Z	1K73	0.71
ANM	ANISOMYCIN	0,1,3,9,A,B,C,F,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	3CC4	0.71
PNV	(2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-(2-PHENOXYACETAMIDO)-4-THIA-1- AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID	A,C	2Z71	0.72
PNV	(2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-(2-PHENOXYACETAMIDO)-4-THIA-1- AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID	A	2EX9	0.72
PI5	N-[3-(8-SEC-BUTYL-7,10-DIOXO-2-OXA-6,9-DIAZA-BICYCLO[11.2.2]HEPTADECA-1(16),13(17),14- TRIEN-11-YLAMINO)-2-HYDROXY-1-(4-HYDROXY-BENZYL)-PROPYL]-3-METHYL-2- (2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE	A,B	1B6K	0.71
AXL	2-{1-[2-AMINO-2-(4-HYDROXY-PHENYL)-ACETYLAMINO]-2-OXO-ETHYL}-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID	B	1LL9	0.7
MAX	MATAIRESINOL	A	2BGM	0.7
ABY	N-(4-AMINOBUTANOYL)-S-(4-METHOXYBENZYL)-L-CYSTEINYLGLYCINE	A,B	1PL2	0.74
ABY	N-(4-AMINOBUTANOYL)-S-(4-METHOXYBENZYL)-L-CYSTEINYLGLYCINE	A,B	1PL1	0.74
322	[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid	A,B	3D1G	0.81
MFM	(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID	A,B	1ZXV	0.73
4SR	(4S)-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRROLIDIN-2-ONE	A,B	1XN0	0.7
ADF	4-{[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHOXY}-3-TERT-BUTYLBENZOIC ACID	A	2G5P	0.7
429	2-{4-[2-ACETYLAMINO-3-(4-CARBOXYMETHOXY-3-HYDROXY-PHENYL)-PROPIONYLAMINO]-BUTOXY}-6-HYDROXY-BENZOIC ACID METHYL ESTER	A	1QXK	0.7
ROL	ROLIPRAM	A,B,C,D	1OYN	0.7
ROL	ROLIPRAM	A,B	1XMY	0.7
ROL	ROLIPRAM	A,B,C,D	1Q9M	0.7
ROL	ROLIPRAM	A,B	1RO6	0.7
ROL	ROLIPRAM	A,B	1XN0	0.7
ROL	ROLIPRAM	A,B	1TBB	0.7
Y12	4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE	A	2EW5	0.73